Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heteromultimerization of Cannabinoid CB1 Receptor and Orexin OX1 Receptor Generates a Unique Complex in Which Both Protomers Are Regulated by Orexin A
Richard J. Ward, John D. Pediani, Graeme Milligan
Journal of Biological Chemistry (2011) Vol. 286, Iss. 43, pp. 37414-37428
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives
Sergi Ferré, Vicent Casadó, Lakshmi A. Devi, et al.
Pharmacological Reviews (2014) Vol. 66, Iss. 2, pp. 413-434
Open Access | Times Cited: 527
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Progress in Lipid Research (2016) Vol. 62, pp. 107-128
Closed Access | Times Cited: 324
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Lucía Callén, Estefanía Moreno, Pedro Barroso‐Chinea, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 25, pp. 20851-20865
Open Access | Times Cited: 214
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
Orexin/hypocretin receptor signalling cascades
Jyrki P. Kukkonen, Christopher S. Leonard
British Journal of Pharmacology (2013) Vol. 171, Iss. 2, pp. 314-331
Open Access | Times Cited: 180
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152
Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders
Tian‐Rui Xu, Yang Yang, Richard J. Ward, et al.
Cellular Signalling (2013) Vol. 25, Iss. 12, pp. 2413-2423
Closed Access | Times Cited: 142
Physiology of the orexinergic/hypocretinergic system: a revisit in 2012
Jyrki P. Kukkonen
AJP Cell Physiology (2012) Vol. 304, Iss. 1, pp. C2-C32
Closed Access | Times Cited: 133
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Labeling and Single-Molecule Methods To Monitor G Protein-Coupled Receptor Dynamics
He Tian, Alexandre Fürstenberg, Thomas Huber
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 186-245
Closed Access | Times Cited: 113
The Prevalence, Maintenance, and Relevance of G Protein–Coupled Receptor Oligomerization
Graeme Milligan
Molecular Pharmacology (2013) Vol. 84, Iss. 1, pp. 158-169
Open Access | Times Cited: 97
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats
Luyi Zhou, Rachel J. Smith, H. Phong, et al.
Neuropharmacology (2012) Vol. 63, Iss. 7, pp. 1201-1207
Open Access | Times Cited: 77
Orexin/Hypocretin Signaling
Jyrki P. Kukkonen
Current topics in behavioral neurosciences (2016), pp. 17-50
Open Access | Times Cited: 67
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Alessandro Papa, Silvia Pasquini, Chiara Contri, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 471-471
Open Access | Times Cited: 29
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues
Martin Cottet, Orestis Faklaris, Damien Maurel, et al.
Frontiers in Endocrinology (2012) Vol. 3
Open Access | Times Cited: 71
OX1 Orexin/Hypocretin Receptor Signaling through Arachidonic Acid and Endocannabinoid Release
Pauli M. Turunen, Maria Jäntti, Jyrki P. Kukkonen
Molecular Pharmacology (2012) Vol. 82, Iss. 2, pp. 156-167
Closed Access | Times Cited: 63
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
África Flores, Rafaël Maldonado, Fernando Berrendero
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 63
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Shaun Yon‐Seng Khoo, Robyn M. Brown
CNS Drugs (2014) Vol. 28, Iss. 8, pp. 713-730
Open Access | Times Cited: 58
Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands
Eugenia Sergeev, Anders Højgaard Hansen, Sunil K. Pandey, et al.
Journal of Biological Chemistry (2015) Vol. 291, Iss. 1, pp. 303-317
Open Access | Times Cited: 54
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Sandra Blasco-Benito, Estefanía Moreno, Marta Seijo-Vila, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 9, pp. 3863-3872
Open Access | Times Cited: 51
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 32
Orexin Signaling: A Complex, Multifaceted Process
Natasha C. Dale, Daniël Hoyer, Laura H. Jacobson, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top